ArticleWorld journal of clinical cases2022

Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis.

Hua-Hua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.